{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fhdv-emerging-agents-xxsXZlDi","width":444,"version":"1.0","type":"rich","title":"Rational Use of New and Emerging Agents for Hepatitis Delta Virus","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/466151ed-f724-4cf0-b364-75f86e694460/cliniciansxchange-id-pod532-hdv-emerging-agents-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/ab470917-50c1-46a8-9e52-ea25b14b91b7\" height=\"200\" width=\"100%\" title=\"Rational Use of New and Emerging Agents for Hepatitis Delta Virus\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Several emerging agents will soon be available for the treatment of hepatitis delta virus (HDV). Hear experts discuss rational use and combinations of new agents to treat patients with HDV."}